Volume 26, Number 5—May 2020
CME ACTIVITY - Research
Blastomycosis in Minnesota, USA, 1999–2018
Table 1
Category | All patients, n = 671 | Patients with nonfatal cases, n = 602 | Patients with fatal cases, n = 64 | OR (95% CI)† | p value† |
---|---|---|---|---|---|
Mean age ± SD, y |
44 ± 19.2 |
42 ± 18.5 |
57 ± 20.7 |
p<0.001‡ |
|
Sex | NS | ||||
M | 474 (71) | 426 (71) | 45 (70) | ||
F |
197 (29) |
176 (29) |
19 (30) |
||
Race | NS | ||||
White | 490 (83) | 446 (84) | 44 (75) | ||
American Indian/Alaska Native | 40 (7) | 32 (6) | 7 (12) | ||
Black | 31 (5) | 27 (5) | 3 (5) | ||
Asian/Pacific Islander | 23 (4) | 19 (4) | 4 (7) | ||
Other/Mixed race |
4 (1) |
4 (1) |
0 |
||
Ethnicity | NS | ||||
Non-Hispanic | 439 (96) | 398 (96) | 41 (95) | ||
Hispanic |
18 (4) |
16 (4) |
2 (5) |
||
Location of disease | NS | ||||
Pulmonary only | 469 (72) | 425 (72) | 43 (69) | ||
Disseminated | 137 (21) | 117 (20) | 19 (31) | ||
Nonpulmonary |
46 (7) |
46 (8) |
0 |
||
Concurrent conditions | |||||
Any | 195 (35) | 157 (30) | 36 (71) | 5.3 (2.7–10.5) | p<0.001 |
Chronic illnesses | 109 (22) | 87 (19) | 20 (57) | 5.5 (2.6–11.6) | p<0.001 |
Diabetes mellitus | 81 (17) | 68 (16) | 11 (42) | 3.6 (1.5–8.7) | p = 0.005 |
Chronic lung disease | 15 (4) | 11 (3) | 4 (21) | 10.2 (2.7–38.6) | p<0.001 |
Immunocompromise | 46 (11) | 34 (8) | 12 (44) | 8.6 (3.4–21.8) | p<0.001 |
Steroid use | 15 (4) | 8 (2) | 7 (32) | 21.1 (6.3–70.8) | p<0.001 |
Rheumatoid arthritis treatment | 13 (3) | 9 (2) | 4 (21) | 10.6 (2.3–48.8) | p = 0.002 |
Cancer | 24 (6) | 19 (5) | 5 (25) | 7.7 (2.4–25.5) | p<0.001 |
*Values are no. (%) except as indicated. Denominators may not be same across categories because not all data were available for all patients. OR, odds ratio; NS, not significant.
†ORs and p values calculated by using univariable logistic regression, except for concurrent conditions analyses, which were controlled for race and sex.
‡p value calculated by using Student t test.
Page created: April 16, 2020
Page updated: April 16, 2020
Page reviewed: April 16, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.